You just read:

Sutro ADC Targeting CD74 Exhibits Potent Anti-tumor Activity in Multiple Malignant Cell Lines and Animal Models of Non-Hodgkin Lymphoma and Multiple Myeloma

News provided by

Sutro Biopharma Inc.

06 Dec, 2016, 08:00 ET